Insights from knock-out models concerning postischemic release of TNFα from isolated mouse hearts

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 1, 2007, Pages 133-141

  Reil, J C ^a   Gilles, S ^a   Zahler, S ^a   Brandl, A ^a   Drexler, H ^b   Hultner L ^c   Matrisian, L M ^d   Welsch, U ^a   Becker, B F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Dept of Cancer Biology ^*  (United States)

Author keywords

Acute ischemia; Cytokines; Isolated mouse hearts; Oxidant stress; Reperfusion

Indexed keywords

CELL PROTEIN; CYCLOHEXIMIDE; INTERLEUKIN 6; MATRILYSIN; STEM CELL FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; KNOCKOUT MOUSE; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; REPERFUSION INJURY;

ANIMALS; CYCLOHEXIMIDE; HEART; HEART VENTRICLES; HISTAMINE RELEASE; INTERLEUKIN-6; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 7; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845646443     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.09.020     Document Type: Article

References (53)

1. Vilcek J., and Lee T.H. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266 (1991) 7313-7316
2. Galli S.J. New concepts about mast cells. N. Engl. J. Med. 328 (1993) 257-265
3. Giroir B.P., Johnson J.H., Brown T., et al. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90 (1992) 693-698
4. Meldrum D.R. Tumor necrosis factor in the heart. Am. J. Physiol. 274 (1998) R577-R595
5. Neumann F.J., Ott I., Gawaz M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
6. Massoudy P., Zahler S., Freyholdt T., et al. Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. J. Thorac. Cardiovasc. Surg. 119 (2000) 566-574
7. Gilles S., Zahler S., Welsch U., et al. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc. Res. 60 (2003) 606-616
8. Frangogiannis N.G., Lindsey M.L., Michael LH., et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98 (1998) 699-710
9. Marx N., Neumann F.J., Ott I., et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J. Am. Coll. Cardiol. 30 (1997) 165-170
10. Irwin M.W., Mak S., Mann D.L., et al. Tissue expression and immunolocation of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99 (1999) 1492-1498
11. 2. Role in cell survival following oxidant injury. J. Biol. Chem. 271 (1996) 4138-4142
12. Kupatt C., Habazettl H., Goedecke A., et al. Tumor necrosis factor-α contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ. Res. 84 (1999) 392-400
13. Black R.A., Rauch C.T., Kozlosky C.J., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
14. Moss M.L., JIN S.L., Milla M.E., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
15. Maurer M., Echtenacher B., Hültner L., et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188 (1998) 2343-2348
16. Pfeffer K., Matsuyama T., Kundig T.M., et al. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
17. Fuchs M., Hilfiker A., Kaminski K., et al. Role of interleukin-6 for left ventricular remodeling and survival after experimental myocardial infarction. FASEB J. 17 (2003) 2118-2120
18. L. Wilson, K. Heppner, P. Labosky et al., Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. 94 1402-1407.
19. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail. Rev. 6 (2001) 71-80
20. Kubota T., Mc Tiernan C.F., Frye C.S., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ. Res. 81 (1997) 627-635
21. Kubota T., Mc Tiernan C.F., Frye C.S., et al. Cardiac-specific overexpression of tumor necrosis factor-α causes lethal myocarditis in transgenic mice. J. Card. Fail. 3 (1997) 117-124
22. Kapadia S., Lee J., Torre-Amione G., et al. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J. Clin. Invest. 96 (1995) 1042-1052
23. Mann D.L. Stress-activated cytokines and the heart: from adaption to maladaption. Annu. Rev. Physiol. 65 (2003) 81-101
24. Zweier J.L., Kuppusamy P., Williams R., et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J. Biol. Chem. 264 (1989) 18890-18895
25. Pogrebniak H.W., Matthews W.A., and Pass H.I. Reactive oxygen species can amplify macrophage tumor necrosis factor production. Surg. Forum 16 (1990) 101-103
26. Hattler B.G., Zeevi A., Oddis C.V., et al. Cytokine induction during cardiac surgery: analysis of TNF-alpha expression pre- and postcardiopulmonary bypass. J. Card. Surg. 10 (1995) 418-422
27. Chandrasekar B., and Freeman G.L. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett. 401 (1997) 30-34
28. Beutler B., and Kruys V. Liposaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J. Cardiovasc. Pharmacol. 25 (1995) 552-554
29. Dinarello C.A., and Margolis N.H. Stopping the cuts: the recently discovered enzymes that process the precursors of inflammatory cytokines are good targets for the design of new antiinflammatory therapeutic agents. Curr. Biol. 5 (1995) 587-590
30. Haro H., Crawford H.C., Fingleton B., et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J. Clin. Invest. 105 (2000) 143-150
31. Mohan M.J., Seaton T., Mitchell J., et al. The tumor necrosis factor-α converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41 (2002) 9462-9469
32. Bader T., and Wietzerbin J. Nuclear accumulation of interferon gamma. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11831-11835
33. Herskowitz A., Choi S., Ansari A.A., et al. Cytokine mRNA expression in postischemic/reperfused myocardium. Am. J. Pathol. 146 (1995) 419-428
34. Gurevitch J., Frolkis I., Yuhas Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J. Am. Coll. Cardiol. 30 (1997) 1554-1561
35. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
36. Gurevitch J., Frolkis I., Yuhas Y., et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J. Am. Coll. Cardiol. 28 (1996) 247-252
37. Sack M.N. Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease. Pharmacol. Ther. 94 (2002) 123-135
38. Dörge H., Schulz R., Belosjorow S., et al. Coronary microembolization: the role of TNFa in contractile dysfunction. J. Mol. Cell. Cardiol. 34 1 (2002) 51-62
39. Dewald O., Ren G., Duerr G.D., et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 164 2 (2004 (Feb)) 665-677
40. Rosendahl M.S., Ko S.C., Long D.L., et al. Identification and characterisation of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. JBC 272 39 (1997) 24588-24593
41. Lindsey M.L., Escobar G.P., Mukherjee R., et al. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction and survival after myocardial infarction. Circulation 113 (2006) 2919-2928
42. Becker B.F., Gilles S., Sommerhoff C.P., et al. Application of peptides containing the cleavage sequency of pro-TNFα in assessing TACE activity of whole cells. Biol. Chem. 383 (2002) 1821-1826
43. Becker B.F., Gilles S., Gonscherowski V., et al. Assessing experimental models in myocardial injury: lack of activation of the proteases TACE and Calpain in brief ischemia and reperfusion. Heart Lung Circ. 12 (2003) 51-59
44. Chida Y., Sudo N., Montomura Y., et al. Electric foot-shock stress drives TNF-alpha production in the liver of IL-6-deficient mice. Neuroimmunomodulation 11 6 (2004) 419-424
45. van Enckevort F.H., Sweep C.G., Span P.N., et al. Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J. Endocrinol. Invest. 24 10 (2001) 786-795
46. Yang R., Han X., Uchiyama T., et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol.: Gastrointest Liver Physiol. 285 (2003) G621-G629
47. Keller C., Keller P., Giralt M., et al. Exercise normalises overexpression of TNF-alpha in knock out mice. Biochem. Biophys. Res. Commun. 321 1 (2004) 179-182
48. Kapadia S., Oral H., Lee J., et al. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circulation Research 81 (1997) 187-195
49. Hammond G.L., Wieben E., and Markert C.l. Molecular signals for initiating protein synthesis in organ hypertrophy. Proc. Natl. Acad. Sci. 76 (1979) 2455-2459
50. Eddy L.J., Goeddel D.V., and Wong G.H.W. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 184 (1992) 1056-1059
51. Nakano M., Knowlton A.A., and Dibbs Z. Tumor necrosis factor-α confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97 (1998) 1392-1400
52. Maekawa N., Hisayasu W., Tsugiyasu K., et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α. Am. J. Coll. Cardiol. 39 (2002) 1229-1235
53. Kurrelmeier K.M., Michael L.H., and Baumgarten G. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5456-5461